{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:14:15Z","timestamp":1791216855755,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P01 CA098912"],"award-info":[{"award-number":["P01 CA098912"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","cancerletters.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.canlet.2015.05.019","type":"journal-article","created":{"date-parts":[[2015,5,21]],"date-time":"2015-05-21T09:44:11Z","timestamp":1432201451000},"page":"89-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Three-dimensional (3D) culture of bone-derived human 786-O renal cell carcinoma retains relevant clinical characteristics of bone metastases"],"prefix":"10.1016","volume":"365","author":[{"given":"Tianhong","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliza L.S.","family":"Fong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariane","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue-Hwa","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary C.","family":"Farach-Carson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Satcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2015.05.019_bib0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/annonc\/mdi002","article-title":"Renal cell carcinoma: review of novel single-agent therapeutics and combination regimens","volume":"16","author":"Amato","year":"2005","journal-title":"Ann. Oncol"},{"key":"10.1016\/j.canlet.2015.05.019_bib0015","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.canlet.2005.08.020","article-title":"Parathyroid hormone-related protein in human renal cell carcinoma","volume":"240","author":"Sourbier","year":"2006","journal-title":"Cancer Lett"},{"key":"10.1016\/j.canlet.2015.05.019_bib0020","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ctrv.2007.12.001","article-title":"Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review","volume":"34","author":"Gupta","year":"2008","journal-title":"Cancer Treat. Rev"},{"key":"10.1016\/j.canlet.2015.05.019_bib0025","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ctrv.2011.06.011","article-title":"Skeletal metastasis in renal cell carcinoma: current and future management options","volume":"38","author":"Wood","year":"2012","journal-title":"Cancer Treat. Rev"},{"key":"10.1016\/j.canlet.2015.05.019_bib0030","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.bone.2010.09.008","article-title":"Skeletal complications and survival in renal cancer patients with bone metastases","volume":"48","author":"Woodward","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.canlet.2015.05.019_bib0035","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1089\/teb.2007.0150","article-title":"Three-dimensional cell culture matrices: state of the art","volume":"14","author":"Lee","year":"2008","journal-title":"Tissue Eng. Part B Rev"},{"key":"10.1016\/j.canlet.2015.05.019_bib0040","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.canlet.2007.03.012","article-title":"Human bone marrow stromal cells enhance breast cancer cell growth rates in a cell line-dependent manner when evaluated in 3D tumor environments","volume":"254","author":"Sasser","year":"2007","journal-title":"Cancer Lett"},{"key":"10.1016\/j.canlet.2015.05.019_bib0045","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.cell.2007.08.006","article-title":"Modeling tissue morphogenesis and cancer in 3D","volume":"130","author":"Yamada","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2015.05.019_bib0050","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/wsbm.1174","article-title":"Hydrogels for in vivo-like three-dimensional cellular studies","volume":"4","author":"DeVolder","year":"2012","journal-title":"WIREs Syst. Biol. Med"},{"key":"10.1016\/j.canlet.2015.05.019_bib0055","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.addr.2014.06.004","article-title":"Bioengineering 3D environments for cancer models","volume":"79\u201380","author":"Alemany-Ribes","year":"2014","journal-title":"Adv. Drug Deliv. Rev"},{"key":"10.1016\/j.canlet.2015.05.019_bib0060","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.semcancer.2005.05.005","article-title":"Three-dimensional co-culture models to study prostate cancer growth, progression, and metastasis to bone","volume":"15","author":"Wang","year":"2005","journal-title":"Semin. Cancer Biol"},{"key":"10.1016\/j.canlet.2015.05.019_bib0065","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1476-4598-12-112","article-title":"Bone-stromal cells up-regulate tumourigenic markers in a tumour-stromal 3D model of prostate cancer","volume":"12","author":"Windus","year":"2013","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2015.05.019_bib0070","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1021\/mp500085p","article-title":"Hydrogel-based 3D model of patient-derived prostate xenograft tumors suitable for drug screening","volume":"11","author":"Fong","year":"2014","journal-title":"Mol. Pharm"},{"key":"10.1016\/j.canlet.2015.05.019_bib0075","doi-asserted-by":"crossref","first-page":"6076","DOI":"10.1016\/j.biomaterials.2009.07.054","article-title":"Hyaluronic acid-based hydrogels as 3D matrices for in vitro evaluation of chemotherapeutic drugs using poorly adherent prostate cancer cells","volume":"30","author":"Gurski","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.canlet.2015.05.019_bib0080","doi-asserted-by":"crossref","first-page":"9049","DOI":"10.1016\/j.biomaterials.2012.08.061","article-title":"Recreating the tumor microenvironment in a bilayer, hyaluronic acid hydrogel construct for the growth of prostate cancer spheroids","volume":"33","author":"Xu","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.canlet.2015.05.019_bib0085","doi-asserted-by":"crossref","first-page":"e50075","DOI":"10.1371\/journal.pone.0050075","article-title":"Hyaluronan (HA) interacting proteins RHAMM and hyaluronidase impact prostate cancer cell behavior and invadopodia formation in 3D HA-based hydrogels","volume":"7","author":"Gurski","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2015.05.019_bib0090","doi-asserted-by":"crossref","first-page":"e89880","DOI":"10.1371\/journal.pone.0089880","article-title":"Cadherin-11 in renal cell carcinoma bone metastasis","volume":"9","author":"Satcher","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2015.05.019_bib0095","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.neuroscience.2009.08.014","article-title":"Rapamycin protects against rotenone-induced apoptosis through autophagy induction","volume":"164","author":"Pan","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.canlet.2015.05.019_bib0100","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jns.2008.06.007","article-title":"Decreased NURR1 gene expression in patients with Parkinson's disease","volume":"273","author":"Le","year":"2008","journal-title":"J. Neurol. Sci"},{"key":"10.1016\/j.canlet.2015.05.019_bib0105","doi-asserted-by":"crossref","first-page":"772","DOI":"10.2174\/156800910793605839","article-title":"Concomitant CXCR4 and CXCR7 expression predicts poor prognosis in renal cancer","volume":"10","author":"D'Alterio","year":"2010","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.canlet.2015.05.019_bib0110","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1476-4598-5-56","article-title":"Stromal derived factor-1 (SDF-1\/CXCL12) and CXCR4 in renal cell carcinoma metastasis","volume":"5","author":"Pan","year":"2006","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2015.05.019_bib0115","doi-asserted-by":"crossref","first-page":"626340","DOI":"10.1155\/2008\/626340","article-title":"Strong expression of chemokine receptor CXCR4 by renal cell carcinoma correlates with advanced disease","volume":"2008","author":"Wehler","year":"2008","journal-title":"J. Oncol"},{"key":"10.1016\/j.canlet.2015.05.019_bib0120","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/jor.21500","article-title":"Unique angiogenic and vasculogenic properties of renal cell carcinoma in a xenograft model of bone metastasis are associated with high levels of vegf-a and decreased ang-1 expression","volume":"30","author":"Xie","year":"2012","journal-title":"J. Orthop. Res"},{"key":"10.1016\/j.canlet.2015.05.019_bib0125","doi-asserted-by":"crossref","first-page":"F649","DOI":"10.1152\/ajprenal.00028.2004","article-title":"Expression of angiopoietins in renal epithelial and clear cell carcinoma cells: regulation by hypoxia and participation in angiogenesis","volume":"287","author":"Yamakawa","year":"2004","journal-title":"Am. J. Physiol. Renal Physiol"},{"key":"10.1016\/j.canlet.2015.05.019_bib0130","first-page":"3325","article-title":"Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model","volume":"57","author":"Foster","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2015.05.019_bib0135","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1016\/j.biomaterials.2013.12.080","article-title":"A hydrogel-based tumor model for the evaluation of nanoparticle-based cancer therapeutics","volume":"35","author":"Xu","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.canlet.2015.05.019_bib0140","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/path.2687","article-title":"Androgen depletion up-regulates cadherin-11 expression in prostate cancer","volume":"221","author":"Lee","year":"2010","journal-title":"J. Pathol"},{"key":"10.1016\/j.canlet.2015.05.019_bib0145","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1158\/0008-5472.CAN-09-3016","article-title":"Cadherin-11 increases migration and invasion of prostate cancer cells and enhances their interaction with osteoblasts","volume":"70","author":"Huang","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2015.05.019_bib0150","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1158\/1541-7786.MCR-08-0077","article-title":"Cadherin-11 promotes the metastasis of prostate cancer cells to bone","volume":"6","author":"Chu","year":"2008","journal-title":"Mol. Cancer Res"},{"key":"10.1016\/j.canlet.2015.05.019_bib0155","first-page":"17","article-title":"Cadherin-11-mediated interactions with bone marrow stromal\/osteoblastic cells support selective colonization of breast cancer cells in bone","volume":"33","author":"Tamura","year":"2008","journal-title":"Int. J. Oncol"},{"key":"10.1016\/j.canlet.2015.05.019_bib0160","first-page":"1832","article-title":"Use of the stromal cell-derived factor-1\/CXCR4 pathway in prostate cancer metastasis to bone","volume":"62","author":"Taichman","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2015.05.019_bib0165","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.1128\/MCB.25.15.6415-6426.2005","article-title":"Coordinate regulation of the oxygen-dependent degradation domains of hypoxia-inducible factor 1 alpha","volume":"25","author":"Chan","year":"2005","journal-title":"Mol. Cell. Biol"},{"key":"10.1016\/j.canlet.2015.05.019_bib0170","first-page":"5215","article-title":"Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas","volume":"61","author":"Wiesener","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2015.05.019_bib0175","first-page":"7349","article-title":"Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase\/Akt signaling pathway","volume":"61","author":"Blancher","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2015.05.019_bib0180","first-page":"387","article-title":"Angiopoietin-1\/Tie2 receptor signaling in vascular quiescence and angiogenesis","volume":"25","author":"Fukuhara","year":"2010","journal-title":"Histol. Histopathol"},{"key":"10.1016\/j.canlet.2015.05.019_bib0185","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S8756-3282(02)00685-3","article-title":"Parathyroid hormone-related protein (PTHrP)-(1\u2013139) isoform is efficiently secreted in vitro and enhances breast cancer metastasis to bone in vivo","volume":"30","author":"Guise","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.canlet.2015.05.019_bib0190","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/cncr.11132","article-title":"Mechanisms of osteolytic bone metastases in breast carcinoma","volume":"97","author":"Kakonen","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2015.05.019_bib0195","doi-asserted-by":"crossref","first-page":"626","DOI":"10.2174\/1566524011313040012","article-title":"Understanding and targeting osteoclastic activity in prostate cancer bone metastases","volume":"13","author":"Sottnik","year":"2013","journal-title":"Curr. Mol. Med"},{"key":"10.1016\/j.canlet.2015.05.019_bib0200","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1172\/JCI26239","article-title":"Osteoblast-derived PTHrP is a physiological regulator of bone formation","volume":"115","author":"Martin","year":"2005","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.canlet.2015.05.019_bib0205","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1200\/JCO.2004.06.121","article-title":"Interleukin-6, interleukin-10, and vascular endothelial growth factor in metastatic renal cell carcinoma: prognostic value of interleukin-6 \u2013 from the Groupe Francais d'Immunotherapie","volume":"22","author":"Negrier","year":"2004","journal-title":"J. Clin. Oncol"},{"key":"10.1016\/j.canlet.2015.05.019_bib0210","first-page":"368","article-title":"[Interleukin-6 and bone metastasis of renal cancer: molecular bases and therapeutic implications]","volume":"11","author":"Paule","year":"2001","journal-title":"Prog. Urol"},{"key":"10.1016\/j.canlet.2015.05.019_bib0215","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1172\/JCI117990","article-title":"Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo","volume":"95","author":"de la Mata","year":"1995","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.canlet.2015.05.019_bib0220","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.1210\/endo.140.10.7036","article-title":"A role for interleukin-6 in parathyroid hormone-induced bone resorption in vivo","volume":"140","author":"Grey","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.canlet.2015.05.019_bib0225","doi-asserted-by":"crossref","first-page":"650","DOI":"10.4161\/auto.19226","article-title":"Interleukin-6: a bone marrow stromal cell paracrine signal that induces neuroendocrine differentiation and modulates autophagy in bone metastatic PCa cells","volume":"8","author":"Delk","year":"2012","journal-title":"Autophagy"},{"key":"10.1016\/j.canlet.2015.05.019_bib0230","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/S0002-9440(10)63560-2","article-title":"Receptor activator of nuclear factor kappaB ligand (RANKL)\/osteoprotegerin (OPG) ratio is increased in severe osteolysis","volume":"163","author":"Grimaud","year":"2003","journal-title":"Am. J. Pathol"},{"key":"10.1016\/j.canlet.2015.05.019_bib0235","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.molmed.2005.11.007","article-title":"RANKL-RANK signaling in osteoclastogenesis and bone disease","volume":"12","author":"Wada","year":"2006","journal-title":"Trends Mol. Med"},{"key":"10.1016\/j.canlet.2015.05.019_bib0240","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/ctrv.2000.0210","article-title":"Metastatic bone disease: clinical features, pathophysiology and treatment strategies","volume":"27","author":"Coleman","year":"2001","journal-title":"Cancer Treat. Rev"},{"key":"10.1016\/j.canlet.2015.05.019_bib0245","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1634\/theoncologist.2010-0154","article-title":"The role of RANK-ligand inhibition in cancer: the story of denosumab","volume":"16","author":"Castellano","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.canlet.2015.05.019_bib0250","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/path.2567","article-title":"Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas","volume":"218","author":"Mikami","year":"2009","journal-title":"J. Pathol"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383515003596?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383515003596?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,25]],"date-time":"2019-08-25T07:07:07Z","timestamp":1566716827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383515003596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0304383515003596"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2015.05.019","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Three-dimensional (3D) culture of bone-derived human 786-O renal cell carcinoma retains relevant clinical characteristics of bone metastases","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2015.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}